Aln-Ttr01

Transthyretin Mediated Amyloidosis (ATTR)

Alnylam PharmaceuticalsPhase 1

—

Rating in progress

Aln-Ttr01 in Transthyretin Mediated Amyloidosis (ATTR) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant